Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1599 of 6351
-
Could a sleep hormone ease diabetic nerve damage?
Disease control Recruiting nowThe aim of the current study is to measure the effect of melatonin as adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in type 2 diabetic patients with diabetic peripheral neuropathy.
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New MS drug trial targets chinese patients
Disease control OngoingThe main purpose of this study is to evaluate the efficacy of ocrelizumab in participants with relapsing multiple sclerosis (RMS) and to characterize the ocrelizumab pharmacodynamic (PD) profile in Chinese participants with primary progressive multiple sclerosis (PPMS).
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New diabetes drug BGM0504 takes on semaglutide in major trial
Disease control Recruiting nowThis trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes
Phase 3 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Placenta patch may help heal diabetic foot wounds
Disease control CompletedThe purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.
Phase 4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Measles mystery: how a virus both harms and helps immunity
Knowledge-focused Recruiting nowThe measles (MeV) paradox refers to an apparent contradiction: natural measles causes a transient but profound immune suppression putting patients at risk for opportunistic infections for years, while at the same time MeV infection induces robust immune activation leading to life…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New approach aims to tame immune storms in Half-Matched transplants
Disease control Recruiting nowTo evalute the safety and efficacy in reducing Cytokine Release Syndrome after hematopoietic stem cell transplantation by introducing immunosuppression earlier in the transplant process
Phase 2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Radiation-Free catheter could make aortic surgery safer
Symptom relief Recruiting nowThis is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable. Primary objective is to demonstrate that the average procedure fluoroscopy …
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple nutrient supplement boost malaria protection in kids?
Disease control OngoingIn the Sahel, the malaria and malnutrition seasons overlap during the rainy season, from approximately July through October. Malaria transmission increases due to the rain and collection of standing water and malnutrition risk increases because this period is the growing season, …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Peptide PET scan could light up hidden cancer targets
Diagnosis By invitation onlyTumors are one of the major diseases threatening human health, among which solid tumors account for a considerable proportion. Nectin-4, as an important cell adhesion molecule, shows a highly expressed state in various solid tumors. In triple-negative breast cancer, the high expr…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Which rehab therapy best restores arm function after stroke?
Disease control CompletedThis study aimed to compare the effects of these three interventions on upper limb motor recovery in stroke survivors. A three-arm randomized controlled trial was conducted in which eligible participants (N=90) with post-stroke upper limb hemiparesis were randomly allocated into…
Sponsor: Foundation of Medical Research and Laboratories, Pakistan • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a tracer that hunts unstable iron light up hidden tumors?
Diagnosis Recruiting nowThis phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissu…
Phase 1 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Can a new measuring ring make mitral valve repair more precise?
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate a novel paired-ring mitral annuloplasty sizing system in humans.
Sponsor: Endeavor Health • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Virtual reality may offer drug-free pain relief during prenatal needle procedures
Symptom relief Recruiting nowThis is a single-site randomized controlled pilot study at Mount Sinai Hospital evaluating the effect of virtual reality on procedural pain and anxiety in obstetric patients undergoing ultrasound-guided needle procedures. Patients will be randomized to receive either VR or standa…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New hope for kidney cancer: ivonescimab trial launches
Disease control Recruiting nowTo learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New cancer drug YL217 enters first human tests
Disease control Recruiting nowA Phase 1 First-in-Human study of YL217 in Patients with Advanced Solid Tumors
Phase 1 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to ease 'Brain Fog' after concussion
Symptom relief Recruiting nowPersistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both assoc…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could 'Abnormal' embryos be hidden gems in IVF?
Knowledge-focused Recruiting nowThe goal of this observational study is to determine the diploidy rate of haploid and triploid embryos from in vitro fertilization (IVF) cycles. The main questions it aims to answer are: * Can a molecular genetic fertilization check of abnormally fertilized embryos be used to ex…
Sponsor: Igenomix • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could a shorter radiation schedule improve cervical cancer treatment?
Disease control Recruiting nowCancer of the uterine cervix is one of the most common gynecologic cancer diagnosis and cause of death among gynecologic cancers worldwide .The two major histologic types of cervical cancer are squamous cell carcinoma, adenocarcinoma and the preinvasive disease that corresponds w…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Ambulance EEG could cut stroke treatment delays by an hour
Diagnosis Recruiting nowEndovascular thrombectomy (EVT) is the standard treatment for large vessel occlusion (LVO) strokes, but it can only be performed in specialized hospitals. Since ambulance personnel cannot determine if a patient is eligible for EVT, 54% of LVO stroke patients are initially taken t…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Could a common steroid save kids from septic shock?
Disease control CompletedAlthough, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contribut…
Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC